Newsbenzinga
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
· Published
Article summary
Aspire Biopharma (NASDAQ: ASBP) completes $30M cash acquisition of Dura Driver Control Systems, adding $200M+ in annual revenue.
An excerpt from the original article.
Comments —
Loading comments…